Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.
Submissions from 2021
6-22-2021 The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach, Matthew Greenhawt, Section of Allergy and Clinical Immunology, Food Challenge and Research Unit, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo., Elissa M. Abrams, Department of Pediatrics and Child Health, Section of Allergy and Immunology, The University of Manitoba, Winnipeg, Man, Canada., Marcus Shaker, Dartmouth-Hitchcock Medical Center, Section of Allergy and Immunology, Lebanon; Dartmouth Geisel School of Medicine, Hanover, NH., et al.
6-2021 Dupilumab Increases Aspirin Tolerance in Aspirin-Exacerbated Respiratory Disease, S Shahzad Mustafa, Rochester Regional Health and Karthik Vadamalai, Mercy Hospital, Springfield, Mo.
5-16-2021 Differences in Oral Food Challenge Reaction Severity Based on Increasing Age in a Pediatric Population, Katie Kennedy, Children's Hospital of Philadelphia, Philadelphia, PA, Maria Katerina C. Alfaro, Children's Hospital of Philadelphia, Philadelphia, PA, Zachary C. Spergel, University of Rochester, Rochester, NY, et al.
5-2021 Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations During the COVID-19 Pandemic, S. Shahzad Mustafa, Rochester Regional Health; Karthik Vadamalai, Mercy Hospital, Springfield, Mo.; and Allison Ramsey, Rochester Regional Health
5-1-2021 Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelines, Susan Waserman, McMaster University, Heather Cruickshank, McMaster University, Kyla J. Hildebrand, The University of British Columbia, et al.
4-23-2021 Rheumatology Patient Satisfaction With Telemedicine During the COVID-19 Pandemic in the United States, Mahta Mortezavi, Rochester Regional Health, Sravani Lokineni, Rochester Regional Health, Megha Garg, Rochester Regional Health, et al.
4-6-2021 Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports [letter], S Shahzad Mustafa, Rochester Regional Health; Allison Ramsey, Rochester Regional Health; and Mary L. Staicu, Rochester Regional Health
4-5-2021 Adult Peanut Allergy, What We Know and What We Need to Learn, Soheila J. Maleki, United States Department of Agriculture, Agricultural Research Service; Suzanne S. Teuber, UC Davis School of Medicine; and S Shahzad Mustafa, Rochester Regional Health
4-1-2021 Examining the impact of a penicillin allergy skin testing brochure on inpatient perceptions: A pre-post intervention study, Mikaela Brown, St. John Fisher College, Joy Uzoma, St. John Fisher College, Ryan Vansice, St. John Fisher College, et al.
4-1-2021 Paediatric Allergy Practice in the Era of Coronavirus Disease 2019, S. Shahzad Mustafa, Rochester Regional Health, Marcus S. Shaker, Dartmouth-Hitchcock Medical Center, Daniel Munblit, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom, et al.
2-16-2021 Drug Allergy Labels Lost in Translation: From Patient to Charts and Backwards, Allison Ramsey, Rochester Regional Health, Eric Macy, Kaiser Permanente Southern California, San Diego, Calif., Anca-Mirela Chiriac, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France, et al.
2-1-2021 Microarray Analysis of Major Epitopes Among Tree Nut-Allergic Individuals May Explain Patterns of Cross-Desensitization, Stephen Gipson, USDA SRRC, Jacqueline Nesbit, USDA SRRC, Hsiaopo Cheng, USDA SRRC, et al.
2-2021 Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study, John T. Anderson, Clinical Research Center of Alabama, Vincent R. Bonagura, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Juthaporn Cowan, University of Ottawa, et al.
1-1-2021 Five-year follow-up of early intervention peanut oral immunotherapy, Lauren Herlihy, The University of North Carolina at Chapel Hill, Edwin H. Kim, The University of North Carolina at Chapel Hill, A. Wesley Burks, The University of North Carolina at Chapel Hill, et al.
2021 Immunodeficiency Secondary to Malignancies and Biologics, S. Shahzad Mustafa, Rochester Regional Health
1-1-2021 Severity grading system for acute allergic reactions: A multidisciplinary Delphi study, Timothy E. Dribin, Cincinnati Children's Hospital Medical Center, David Schnadower, Cincinnati Children's Hospital Medical Center, Jonathan M. Spergel, University of Pennsylvania Perelman School of Medicine, et al.
Submissions from 2020
10-1-2020 Inpatient Electronic Consultations (E-consults) in Allergy/Immunology, S Shahzad Mustafa, Rochester Regional Health, Mary L. Staicu, Rochester Regional Health, Luanna Yang, Rochester Regional Health, et al.
10-1-2020 Penicillin Allergy Delabeling: A Multidisciplinary Opportunity, Mary L. Staicu, Rochester Regional Health, David Vyles, Medical College of Wisconsin, Erica S. Shenoy, Harvard Medical School, et al.
9-25-2020 Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease, S Shahzad Mustafa, Rochester Regional Health, Karthik Vadamalai, Division of Critical Care, Mercy Hospital, Springfield, Missouri., Bryan Scott, Rochester Regional Health, et al.
9-12-2020 Successful treatment of refractory eosinophilic fasciitis with reslizumab, Mahta Mortezavi, Rochester Regional Health; Mary Barrett, Rochester Regional Health; and Mohammadomid Edrissian, Department of Rheumatology, Kaiser Permanente, South Sacramento, California.
9-1-2020 Appointment characteristics in an allergy/immunology practice in the immediate aftermath of COVID-19 restrictions, Allison Ramsey, Rochester Regional Health, Luanna Yang, Rochester Regional Health, Karthik Vadamalai, Mercy Hospital, et al.
9-1-2020 Reply to “Appointment characteristics during COVID-19 restrictions: A Canadian allergy/immunology centre perspective”, Allison Ramsey, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health
8-28-2020 Patient Characteristics and Concerns about Drug Allergy: A Report from the United States Drug Allergy Registry, Kimberly G. Blumenthal, Harvard Medical School, Boston, Mass; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Mongan Institute, Massachusetts General Hospital, Boston, Mass., Tyler Harkness, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Mongan Institute, Massachusetts General Hospital, Boston, Mass., Elizabeth J. Phillips, Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn, et al.
7-11-2020 The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non-Hodgkin Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab, S Shahzad Mustafa, Rochester Regional Health, Saad Jamshed, Rochester Regional Health, Karthik Vadamalai, Division of Critical Care, Mercy Hospital, Springfield, MO., et al.
7-1-2020 Direct Challenges to Penicillin-Based Antibiotics in the Inpatient Setting, Allison Ramsey, Rochester Regional Health, S Shahzad Mustafa, Rochester Regional Health, Anne Marie Holly, Rochester Regional Health, et al.